Purchase Order 75N92025P00249
Award Date
6/27/25
Potential Completion Date
10/31/25
Potential Value
$25K
Federal Agency
National Heart Lung and Blood Institute
Awardee
Psomagen Inc.
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $24,940 firm-fixed-price purchase order awarded by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) to Psomagen Inc., a genomics and molecular biology services company, to provide products for proteomic analysis on sickle cell plasma as part of ongoing sickle cell research efforts. The contract has an ultimate completion date of December 5, 2025. Psomagen Inc. is a subsidiary of Macrogen, Inc. and a for-profit manufacturer of goods that...
This is a $24,940 firm-fixed-price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services, to Psomagen Inc., a for-profit manufacturer of goods. The contract is for high-throughput, sensitive, and specific protein quantification analysis to maintain the integrity of Batch 3 of sickle cell disease (SCD) patient samples for the NHLBI's Laboratory of Sickle Cell Genetics and Pathophysiology....
This is a $24,000 firm fixed-price purchase order awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency under the National Institutes of Health (NIH), to Psomagen Inc., a for-profit genomics services company. The contract is for providing ongoing Olink proteomics analysis for Batch 2 of sickle cell disease patient samples as part of the NHLBI's Laboratory of Sickle Cell Genetics and Pathophysiology research program. The award is not set aside and has an ultimate...
This is a $24,940 firm fixed-price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Psomagen Inc., a for-profit genomics and molecular biology services company. The contract is to provide plasma protein detection services using a proteomics platform to support NHLBI's ongoing clinical protocol for sickle cell disease research. The contract period of performance is from June 15, 2025 to December 14, 2025. No set-aside designation was...
This $24,940 firm-fixed-price purchase order was awarded by the National Heart Lung and Blood Institute, a civilian agency, to Psomagen Inc., a for-profit manufacturer of genomic and molecular biology services. The contract is to provide the Olink Explore HT platform to support the Sickle Cell Branch's efforts to detect proteomic biomarkers in individuals with sickle cell disease. The award does not have a set-aside designation. Psomagen has previously received other federal contract awards...
This is a $24,940 firm fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Psomagen Inc., a for-profit manufacturer and genomics/molecular biology services company, for Olink proteomic assays to support the Laboratory of Sickle Cell Genetics and Pathophysiology's research on the relationship between the TTR V122I genetic mutation and its protein variant. The award is not associated with a set-aside program and has an ultimate...
This is a federal purchase order contract awarded by the National Heart, Lung and Blood Institute (NHLBI), a civilian agency under the National Institutes of Health (NIH), to Psomagen Inc., a genomics and molecular biology services company. The contract, valued at $15,344.80, is for Psomagen to provide OLINK EXPLORE HT (partial panel use) services to support next-generation sequencing-based proteomics analysis of plasma samples from hospitalized sepsis patients. The contract is not associated...
The National Institutes of Health National Heart Lung and Blood Institute awarded a $484,000 purchase order contract to Psomagen Inc., a subsidiary of Macrogen, Inc., to provide Whole Genome Sequencing on DNA. The contract has a period of performance starting on May 17, 2022 through May 16, 2023 and utilizes a firm fixed price pricing structure. The place of performance will be Potomac, Maryland. Psomagen Inc. will perform whole genome sequencing services on DNA samples for the National Heart...
The National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. government, awarded a $229,104 firm fixed-price purchase order contract to Psomagen Inc., a for-profit organization and manufacturer of goods. The contract, which has no set-aside designation, is for investigating transthyretin (TTR) variants and their impact on sickle cell disease severity using Olink proteomics technology. This contract is part of a larger $500 million single-award Indefinite Delivery...
This $17,154.00 firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services National Institutes of Health, to Psomagen Inc. for library preparation and sequencing services. Psomagen is a for-profit organization that manufactures goods and provides multiomics contract laboratory services, including whole genome, RNA, and epigenomic sequencing. The company has previously supported research at...